Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kohei Taniguchi

Showing results (161-170 of 191) with videos related to

Pageof 20
Sort By:
International Journal of Molecular Sciences|February 10, 2024
Consistency between Primary Uterine Corpus Malignancies and Their Corresponding Patient-Derived Xenograft ModelsShoko Ueda, Tomohito Tanaka, Kensuke Hirosuna, et al.
International Journal of Molecular Sciences|December 23, 2022
Cancer-Specific miRNAs Extracted from Tissue-Exudative Extracellular Vesicles in Ovarian Clear Cell CarcinomaHiroshi Maruoka, Tomohito Tanaka, Hikaru Murakami, et al.
In Vivo (Athens, Greece)|October 29, 2022
A Prospective Study Regarding the Efficacy and Safety of the BNT162b2 Vaccine in Patients With Solid Malignancies Undergoing Systemic ChemotherapyEiki Yamasaki, Fukutaro Shimamoto, Hiroki Nishikawa, et al.
Breast Cancer Research and Treatment|June 18, 2024
Baseline gut microbiota as a predictive marker for the efficacy of neoadjuvant chemotherapy in patients with early breast cancer: a multicenter prospective cohort study in the Setouchi Breast Project-14Shogo Nakamoto, Yukiko Kajiwara, Kohei Taniguchi, et al.
Cancer Science|August 12, 2016
CD10 down expression in follicular lymphoma correlates with gastrointestinal lesion involving the stomach and large intestineNobuhiko Ohnishi, Katsuyoshi Takata, Tomoko Miyata-Takata, et al.
Journal of Clinical Medicine|May 11, 2024
Creation and Validation of Patient-Derived Cancer Model Using Peritoneal and Pleural Effusion in Patients with Advanced Ovarian Cancer: An Early ExperienceRuri Nishie, Tomohito Tanaka, Kensuke Hirosuna, et al.
Oncotarget|June 4, 2015
Intravesical administration of exogenous microRNA-145 as a therapy for mouse orthotopic human bladder cancer xenograftTeruo Inamoto, Kohei Taniguchi, Kiyoshi Takahara, et al.
The American Journal of Surgical Pathology|January 12, 2016
Frequent MYD88 L265P and CD79B Mutations in Primary Breast Diffuse Large B-Cell LymphomaKohei Taniguchi, Katsuyoshi Takata, Shih-Sung Chuang, et al.
Annals of Surgical Oncology|October 22, 2025
ASO Visual Abstract: ESR1 Expression Negatively Correlates with Immune Cell Infiltration and Response to Immune Checkpoint Inhibitors in ER-Positive HER2-Negative Breast CancerJun Arima, Kohei Chida, Rongrong Wu, et al.
Annals of Surgical Oncology|September 16, 2025
ESR1 Expression Negatively Correlates with Immune Cell Infiltration and Response to Immune Checkpoint Inhibitors in Estrogen Receptor-Positive/HER2-Negative Breast CancerJun Arima, Kohei Chida, Rongrong Wu, et al.
Pageof 20

Showing results (161-170 of 191) with videos related to

Sort By:
Pageof 20
International Journal of Molecular Sciences|February 10, 2024
Consistency between Primary Uterine Corpus Malignancies and Their Corresponding Patient-Derived Xenograft ModelsShoko Ueda, Tomohito Tanaka, Kensuke Hirosuna, et al.
International Journal of Molecular Sciences|December 23, 2022
Cancer-Specific miRNAs Extracted from Tissue-Exudative Extracellular Vesicles in Ovarian Clear Cell CarcinomaHiroshi Maruoka, Tomohito Tanaka, Hikaru Murakami, et al.
In Vivo (Athens, Greece)|October 29, 2022
A Prospective Study Regarding the Efficacy and Safety of the BNT162b2 Vaccine in Patients With Solid Malignancies Undergoing Systemic ChemotherapyEiki Yamasaki, Fukutaro Shimamoto, Hiroki Nishikawa, et al.
Breast Cancer Research and Treatment|June 18, 2024
Baseline gut microbiota as a predictive marker for the efficacy of neoadjuvant chemotherapy in patients with early breast cancer: a multicenter prospective cohort study in the Setouchi Breast Project-14Shogo Nakamoto, Yukiko Kajiwara, Kohei Taniguchi, et al.
Cancer Science|August 12, 2016
CD10 down expression in follicular lymphoma correlates with gastrointestinal lesion involving the stomach and large intestineNobuhiko Ohnishi, Katsuyoshi Takata, Tomoko Miyata-Takata, et al.
Journal of Clinical Medicine|May 11, 2024
Creation and Validation of Patient-Derived Cancer Model Using Peritoneal and Pleural Effusion in Patients with Advanced Ovarian Cancer: An Early ExperienceRuri Nishie, Tomohito Tanaka, Kensuke Hirosuna, et al.
Oncotarget|June 4, 2015
Intravesical administration of exogenous microRNA-145 as a therapy for mouse orthotopic human bladder cancer xenograftTeruo Inamoto, Kohei Taniguchi, Kiyoshi Takahara, et al.
The American Journal of Surgical Pathology|January 12, 2016
Frequent MYD88 L265P and CD79B Mutations in Primary Breast Diffuse Large B-Cell LymphomaKohei Taniguchi, Katsuyoshi Takata, Shih-Sung Chuang, et al.
Annals of Surgical Oncology|October 22, 2025
ASO Visual Abstract: ESR1 Expression Negatively Correlates with Immune Cell Infiltration and Response to Immune Checkpoint Inhibitors in ER-Positive HER2-Negative Breast CancerJun Arima, Kohei Chida, Rongrong Wu, et al.
Annals of Surgical Oncology|September 16, 2025
ESR1 Expression Negatively Correlates with Immune Cell Infiltration and Response to Immune Checkpoint Inhibitors in Estrogen Receptor-Positive/HER2-Negative Breast CancerJun Arima, Kohei Chida, Rongrong Wu, et al.
Pageof 20